Linked Life Data

17141830

Source:http://linkedlifedata.com/resource/pubmed/id/17141830

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2006-12-15
pubmed:abstractText
To determine whether nadir prostate-specific antigen (PSA) levels within 12 months (nadir PSA12) after completion of radiotherapy (RT) can be used as an early marker of recurrence risk.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Dec
pubmed:issn
1527-9995
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
68
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1257-62
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failure.
pubmed:affiliation
Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109-0010, USA. mray@umich.edu
pubmed:publicationType
Journal Article